Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Thrombin Generation Impairments in Platelet Function Disorders

Justin Brunet, BSc, Subia Tasneem, PhD, Georges E. Rivard, MD FRCPC, Catherine P.M. Hayward, MD

Blood (2018) 132 (Supplement 1): 1150.

https://doi.org/10.1182/blood-2018-99-110247

Published: 2018

Journal Articles

Immune Tolerance Induction in Hemophilia A Patients Using Wilate® —a Canadian 10 Year Study (PREVAIL)

Paul Moorehead, MD, Mark J. Belletrutti, MD MSc, David Lillicrap, MD FRCPC, Robert J Klaassen, MD FRCPC, Manuel Carcao, MDMSc, Georges E. Rivard, MD FRCPC

Blood (2017) 130 (Supplement 1): 3679.

https://doi.org/10.1182/blood.V130.Suppl_1.3679.3679

Published: 2017

Journal Articles

Transcriptional Landscape of APL Identifies Aberrant Podoplanin Expression As a Defining Feature and Missing Link for the Bleeding Disorder of This Disease

Vincent-Philippe Lavallée, MD, Miriam Marquis, PhD, Marie-Ève Bordeleau, PhD, Jalila Chagraoui, PhD, Tara MacRae, M.Sc., Isabel Boivin, M.Sc, Geneviève Boucher, M.Sc, Patrick Gendron, M.Sc, Sébastien Lemieux, PhD, Arnaud Bonnefoy, PhD, Georges E. Rivard, MD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2016) 128 (22): 1075.

https://doi.org/10.1182/blood.V128.22.1075.1075

Published: 2016

Journal Articles

Bleeding Risks Associated with Confirmed Platelet Dense Granule Deficiency and/or Impaired Aggregation Responses

Janaki Iyer, PhD, Matthew Badin, Lucas Graf, Georges E. Rivard, MD, A. D. Paterson, Guillaume Pare, Catherine P.M. Hayward, MD PhD

Blood (2016) 128 (22): 3728.

https://doi.org/10.1182/blood.V128.22.3728.3728

Published: 2016

Journal Articles

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Brett L. Houston, MD, Christine M. Cserti-Gazdewich, MD, Richard Ward, MBBS, Jean St. Louis, MD, Georges E. Rivard, MD, Jerome M. Teitel, MD, Michelle Sholzberg, MD

Blood (2015) 126 (23): 4701.

https://doi.org/10.1182/blood.V126.23.4701.4701

Published: 2015

Journal Articles

Quebec Platelet Disorder Is Associated With Greater Than Expected Increases In Urokinase Plasminogen Activator In Granulocytes and Monocytes

Jessica Blavignac, PhD(c), H.BSc., Subia Tasneem, PhD, Andrew D Paterson, MD, John S Waye, Ph.D, Bhupinder Bharaj, PhD, Georges E Rivard, MD, Catherine P. M. Hayward, MD, PhD

Blood (2013) 122 (21): 3573.

https://doi.org/10.1182/blood.V122.21.3573.3573

Published: 2013

Journal Articles

Dysregulation of C10orf55 Expression in Megakaryocytic Cell Lineage From Quebec Platelet Disorder Individuals

Natalia Bunimov, PhD, Jessica Blavignac, BSc, Subia Tasneem, PhD, John S Waye, PhD, Andrew D Paterson, MD, Georges E Rivard, MD, Catherine PM Hayward, MD, PhD

Blood (2011) 118 (21): 2274.

https://doi.org/10.1182/blood.V118.21.2274.2274

Published: 2011

Journal Articles

Persons with Quebec platelet disorder have a tandem duplication of PLAU , the urokinase plasminogen activator gene

Andrew D. Paterson, Johanna M. Rommens, Bhupinder Bharaj, Jessica Blavignac, Isidro Wong, Maria Diamandis, John S. Waye, Georges E. Rivard, Catherine P. M. Hayward

Blood (2010) 115 (6): 1264–1266.

https://doi.org/10.1182/blood-2009-07-233965

Published: 2010

Includes: Supplemental data

Journal Articles

The Prevalence of Non-Neutralizing Anti-FVIII Antibodies in the Canadian Hemophilia Population.

David Lillicrap, Angie Tuttle, Eric Crawford, Anne-Marie Vincent, Georges E. Rivard, The Association of Hemophilia Clinic Directors of Canada

Blood (2009) 114 (22): 1291.

https://doi.org/10.1182/blood.V114.22.1291.1291

Published: 2009

Journal Articles

The Prevalence of Anti-Factor VIII Antibodies in the Hemophilia A Population of the Quebec Province of Canada: Results of Testing with the Bethesda/Nijmegen Assay and with Three ELISA Assays.

Anne-Marie Vincent, David Lillicrap, Angie Tuttle, Laurence Dedeken, Christine Demers, Mariette Lépine, Jean St-Louis, Margaret Warner, Georges E. Rivard

Blood (2009) 114 (22): 1308.

https://doi.org/10.1182/blood.V114.22.1308.1308

Published: 2009

Journal Articles

Procoagulant Platelet Subpopulation Formation in Whole Blood: Correlation with Whole Blood Clotting Time and 5-Year Mean Bleeding Score in Individuals with Factor VIII Deficiency.

Beth A. Bouchard, PhD, Aimee Paradis, Georges E. Rivard, Kathleen E. Brummel Ziedins, PhD

Blood (2009) 114 (22): 4022.

https://doi.org/10.1182/blood.V114.22.4022.4022

Published: 2009

Journal Articles

Assay of Factor VIII Antibodies by ELISA Using Plasma Specimens Dried On Filter Paper and Stored at Room Temperature.

Anne-Marie Vincent, David Lillicrap, Angie Tuttle, Angélique Hofer, Anik Cormier, Jean St-Louis, Georges E. Rivard

Blood (2009) 114 (22): 3479.

https://doi.org/10.1182/blood.V114.22.3479.3479

Published: 2009

Journal Articles

Quantitation of anti–factor VIII antibodies in human plasma

Jolanta Krudysz-Amblo, Behnaz Parhami-Seren, Saulius Butenas, Kathleen E. Brummel-Ziedins, Edward D. Gomperts, Georges E. Rivard, Kenneth G. Mann

Blood (2009) 113 (11): 2587–2594.

https://doi.org/10.1182/blood-2008-08-174987

Published: 2009

Journal Articles

Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation

D. Kika Veljkovic, Georges E. Rivard, Maria Diamandis, Jessica Blavignac, Elisabeth M. Cramer-Bordé, Catherine P. M. Hayward

Blood (2009) 113 (7): 1535–1542.

https://doi.org/10.1182/blood-2008-08-172338

Published: 2009

Journal Articles

Quebec platelet disorder is linked to the urokinase plasminogen activator gene ( PLAU ) and increases expression of the linked allele in megakaryocytes

Maria Diamandis, Andrew D. Paterson, Johanna M. Rommens, D. Kika Veljkovic, Jessica Blavignac, Dennis E. Bulman, John S. Waye, Francine Derome, Georges E. Rivard, Catherine P. M. Hayward

Blood (2009) 113 (7): 1543–1546.

https://doi.org/10.1182/blood-2008-08-175216

Published: 2009

Includes: Supplemental data

Journal Articles

Use of Factor VIII/Von Willebrand Factor Complex for Inducing Immune Tolerance in Hemophilia a Patients Who Have Failed with Recombinant Fviii: Recent Canadian Experience

Anne-Marie Vincent, M.D., FRCPC, Anthony Chan, MBBS, Sara J. Israels, MD, Man-Chiu Poon, MD, John K. Wu, MBBS, FRCPC, Georges E. Rivard, MD

Blood (2008) 112 (11): 4520.

https://doi.org/10.1182/blood.V112.11.4520.4520

Published: 2008

Journal Articles

Quantitation of Non-Inhibitory Anti-Factor VIII Antibodies in human Plasma

Jolanta Krudysz-Amblo, Behnaz Parhami-Seren, Ph.D., Saulius Butenas, Ph.D., Kathleen E. Brummel-Ziedins, PhD, Edward D. Gomperts, MBBCH, MD, Georges E. Rivard, MD, Kenneth G. Mann, PhD

Blood (2008) 112 (11): 1025.

https://doi.org/10.1182/blood.V112.11.1025.1025

Published: 2008

Journal Articles

Quebec Platelet Disorder Is Caused by a Cis-Acting Mutation near the Plasminogen Activator Gene (PLAU) That Increases PLAU Transcription by Megakaryocytes.

Maria Diamandis, Andrew D Paterson, PhD, Johanna M Rommens, PhD, D. Kika Veljkovic, MD, Jessica Blavignac, John S Waye, PhD, Francine Derome, Georges E. Rivard, MD, Catherine PM Hayward, MD, PhD

Blood (2008) 112 (11): 3394.

https://doi.org/10.1182/blood.V112.11.3394.3394

Published: 2008

Journal Articles

Proteomics in the Study of Qualitative Platelet Defects: Validation of the Approach in the Gray Platelet Syndrome and Quebec Platelet Disorder.

Raj S. Kasthuri, MBBS, Lorraine B. Anderson, PhD, LeeAnn Higgins, PhD, Jorge Di Paola, MD, Georges E. Rivard, MD, FRCP(C), Catherine P.M. Hayward, MD, PhD, FRCP(C), Nigel S. Key, MB, FRCP

Blood (2007) 110 (11): 3900.

https://doi.org/10.1182/blood.V110.11.3900.3900

Published: 2007

Journal Articles

10 Year Musculoskeletal Outcomes with Tailored Primary Prophylaxis: The Canadian Hemophilia Prophylaxis Study.

Victor S. Blanchette, Georges E. Rivard, Mohan K. Pai, Sara J. Israels, Marjorie McLimont, Brian M. Feldman

Blood (2007) 110 (11): 84.

https://doi.org/10.1182/blood.V110.11.84.84

Published: 2007

NARROW

Thrombin Generation Impairments in Platelet Function Disorders

Immune Tolerance Induction in Hemophilia A Patients Using Wilate® —a Canadian 10 Year Study (PREVAIL)

Transcriptional Landscape of APL Identifies Aberrant Podoplanin Expression As a Defining Feature and Missing Link for the Bleeding Disorder of This Disease

Bleeding Risks Associated with Confirmed Platelet Dense Granule Deficiency and/or Impaired Aggregation Responses

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Quebec Platelet Disorder Is Associated With Greater Than Expected Increases In Urokinase Plasminogen Activator In Granulocytes and Monocytes

Dysregulation of C10orf55 Expression in Megakaryocytic Cell Lineage From Quebec Platelet Disorder Individuals

Persons with Quebec platelet disorder have a tandem duplication of PLAU , the urokinase plasminogen activator gene

The Prevalence of Non-Neutralizing Anti-FVIII Antibodies in the Canadian Hemophilia Population.

The Prevalence of Anti-Factor VIII Antibodies in the Hemophilia A Population of the Quebec Province of Canada: Results of Testing with the Bethesda/Nijmegen Assay and with Three ELISA Assays.

Procoagulant Platelet Subpopulation Formation in Whole Blood: Correlation with Whole Blood Clotting Time and 5-Year Mean Bleeding Score in Individuals with Factor VIII Deficiency.

Assay of Factor VIII Antibodies by ELISA Using Plasma Specimens Dried On Filter Paper and Stored at Room Temperature.

Quantitation of anti–factor VIII antibodies in human plasma

Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation

Quebec platelet disorder is linked to the urokinase plasminogen activator gene ( PLAU ) and increases expression of the linked allele in megakaryocytes

Use of Factor VIII/Von Willebrand Factor Complex for Inducing Immune Tolerance in Hemophilia a Patients Who Have Failed with Recombinant Fviii: Recent Canadian Experience

Quantitation of Non-Inhibitory Anti-Factor VIII Antibodies in human Plasma

Quebec Platelet Disorder Is Caused by a Cis-Acting Mutation near the Plasminogen Activator Gene (PLAU) That Increases PLAU Transcription by Megakaryocytes.

Proteomics in the Study of Qualitative Platelet Defects: Validation of the Approach in the Gray Platelet Syndrome and Quebec Platelet Disorder.

10 Year Musculoskeletal Outcomes with Tailored Primary Prophylaxis: The Canadian Hemophilia Prophylaxis Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only